Trials / Completed
CompletedNCT06775730
A Drug-Drug Interaction Study of S-217622 With Combined Oral Contraceptives in Healthy Adult Female Participants
A Phase 1 Drug-Drug Interaction Study of S-217622 With Combined Oral Contraceptives in Healthy Adult Female Participants
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Shionogi · Industry
- Sex
- Female
- Age
- 18 Years – 35 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to examine the potential for drug-drug interactions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ensitrelvir | Ensitrelvir will be administered per schedule specified in the arm description. |
Timeline
- Start date
- 2024-12-30
- Primary completion
- 2025-04-03
- Completion
- 2025-04-03
- First posted
- 2025-01-15
- Last updated
- 2025-05-04
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06775730. Inclusion in this directory is not an endorsement.